Skip to content
Echoing a bipartisan Senate letter last week, two top House trade leaders are raising serious concerns about the proposed expansion of the World Trade Organization (WTO) […]
House leaders speak out on COVID IP waiver expansion Read More »
Bill Gates’ sustainable energy accelerator Breakthrough Energy provided BIO member LanzaJet with a $50 million grant to build a sustainable aviation fuel (SAF) facility
LanzaJet to build facility producing low-cost SAF with aid from Bill Gates’ accelerator Read More »
The Advisory Committee on Immunization Practices (ACIP), the CDC’s panel of independent vaccination advisers, yesterday recommended adding COVID-19 vaccines to the list of recommended
CDC committee recommends adding COVID vaccines to routine immunization schedules Read More »
In a significant bipartisan statement, eight senators this week sent a letter to U.S. Trade Representative Katherine Tai to express their concerns about a
Letter from bipartisan group of senators expresses concerns over WTO IP waiver Read More »
October 20 is World CRISPR Day, commemorating the day CRISPR was first used to edit a human genome, marking a new era in history.
World CRISPR Day celebrates transformative technology’s impact Read More »
With the goal of managing “the risk of biological incidents, whether naturally occurring, accidental, or deliberate,” President Biden Tuesday signed National Security Memorandum-15 (NSM-15)
Biden releases Biodefense Strategy, involving biotech in national defense Read More »
The FDA on Tuesday announced it had “issued an emergency use authorization (EUA) for the first over-the-counter molecular test authorized for use with saliva
FDA grants EUA to over-the-counter molecular test for COVID-19 Read More »
The impact of climate change includes droughts, fires, and flooding—but it is also driving inflation, according to reports. Treasury Secretary Janet Yellin recently noted
Climate change seen to be driving inflation Read More »
BIO member company Ginkgo Bioworks has partnered with the U.S. Intelligence Advanced Research Projects Activity (IARPA) to utilize the company’s synthetic biology technology for
The most recent illustration of the strength of patient advocacy is the FDA’s approval of new ALS medicine, which was developed with $2 million
Podcast tells of patient advocates improving drug development Read More »
